They also found that NRF2 could promote ALDH1A1 expression and the silencing of NRF2 could enhance the anti-proliferative effects of the chemotherapeutic agent 5-fluorouracil in pancreatic cancer cells (29, 51). The gene discussed is ALDH1A1; the disease is pancreatic neoplasm.